Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Certain hair straighteners and dyes may increase ovarian cancer risk, especially in African American/Black women.

A genetic variant in the androgen receptor gene increases heart disease risk in women but not in men.

Androgen lowering medications don't significantly change HCV-related liver cancer risk in men.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Propranolol is effective and safe for treating infantile hemangioma, but more research is needed for dosing and monitoring guidelines.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Skin diseases like psoriasis, lupus, and others can increase heart disease risk due to factors like chronic inflammation and genetic susceptibility.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Higher levels of PD-L1 are linked to more severe hair loss in people with Alopecia Areata.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Women have unique stroke risks due to hormones, contraceptives, pregnancy, and menopause.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Increasing PBX1 reduces aging and cell death in hair follicle stem cells by boosting SIRT1 and lowering PARP1 activity.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Finasteride may increase suicide risk; more research needed.

Finasteride causes temporary cell death in BPH tissues.

Skin cancer in sun-exposed areas is more likely to come back.

Hair loss in adults is linked to heart disease risk factors like unhealthy blood fats, lack of exercise, and alcohol use. It's also slightly more common in people with metabolic syndrome. As people age, hair loss gets worse. In men, severe hair loss is tied to high blood pressure and a larger waist. In women, it's tied to higher body weight. People with hair loss should be checked for unhealthy blood fats and advised to avoid alcohol and inactivity.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Men with male pattern baldness are more likely to have heart disease risk factors, so they should get heart screenings early.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.